Suki, an AI ambient scribe for healthcare providers, raised a $90M Series E led by Healthier Capital; a source says it projects $60M-$80M in revenue this year
Context & Ripple Effects
Suki has moved through successive financing rounds for its clinician voice-assistant product, including a $70M Series D in 2024 that put total funding at $165M and valued the company at about $500M. Earlier, it reported 40x usage growth following its 2020 Series B, framing the company’s progression from adoption claims toward a source-reported revenue target.
The round lands in an ambient clinical-documentation market where Suki’s earlier physician-focused funding was followed by reporting that Abridge, Nuance and Suki were winning physician adoption. Other healthcare-AI fundraising in 2026, including Sage’s caregiving tools and AcuityMD’s medtech workflow software, shows investors backing AI products tied to specific healthcare workflows.
First-order effects
- Suki receives $90M of new growth capital, while Healthier Capital becomes the lead investor in its Series E.
- The source-reported $60M–$80M revenue projection gives Suki a commercial benchmark alongside its funding history, rather than relying only on product-usage claims.
Second-order effects
- Abridge and Nuance face a better-capitalized Suki in the contest for clinician adoption of ambient documentation tools, increasing the importance of proving workflow value to healthcare providers.
- For healthcare-AI investors, Suki’s round ties late-stage financing more closely to stated revenue expectations, a contrast with the usage-growth framing of its earlier rounds.
Third-order effects
- If revenue projections become a recurring basis for later-stage healthcare-AI funding, vendors embedded in clinical and administrative workflows will be judged more on repeatable commercial scale than on standalone AI capability.
- The pattern points toward a healthcare-AI market in which funding concentrates around products that can turn provider workflow adoption into measurable revenue.
The trend: Healthcare AI is moving from early adoption narratives toward later-stage financing that tests whether workflow tools can produce durable revenue.